当前位置:首页 - 行情中心 - 泓博医药(301230) - 财务分析 - 现金流量表

泓博医药

(301230)

  

流通市值:52.00亿  总市值:57.79亿
流通股本:1.26亿   总股本:1.40亿

现金流量表

报告期2026-03-312025-12-312025-09-302025-06-30
公司类型通用通用通用通用
一、经营活动产生的现金流量:
  销售商品、提供劳务收到的现金154,412,808.38554,924,593.35417,894,006.74259,334,867.87
  收到的税费返还409,896.583,489,204.544,963,589.873,708,973.08
  收到其他与经营活动有关的现金21,709,640.546,457,583.5328,857,588.7818,208,955.72
  经营活动现金流入小计176,532,345.46604,871,381.42451,715,185.39281,252,796.67
  购买商品、接受劳务支付的现金42,920,916.56172,243,284.85130,668,143.9578,928,149.43
  支付给职工以及为职工支付的现金75,662,585.84251,268,300.46179,647,631.85124,075,199.24
  支付的各项税费2,704,255.0212,495,888.2111,799,948.158,623,129.88
  支付其他与经营活动有关的现金25,497,112.6833,351,965.7747,085,149.0330,200,189.38
  经营活动现金流出小计146,784,870.1469,359,439.29369,200,872.98241,826,667.93
  经营活动产生的现金流量净额29,747,475.36135,511,942.1382,514,312.4139,426,128.74
二、投资活动产生的现金流量:
  收回投资收到的现金160,818,302.3923,000,00020,000,00020,000,000
  取得投资收益收到的现金6,807,055.73105,380.53105,380.53105,380.53
  处置固定资产、无形资产和其他长期资产收回的现金净额270121,442--
  投资活动现金流入小计167,625,628.1223,226,822.5320,105,380.5320,105,380.53
  购建固定资产、无形资产和其他长期资产支付的现金17,318,035.7843,316,262.0130,394,584.7117,276,315.2
  投资支付的现金154,800,00023,300,00023,300,00010,000,000
  投资活动现金流出小计172,118,035.7866,616,262.0153,694,584.7127,276,315.2
  投资活动产生的现金流量净额-4,492,407.66-43,389,439.48-33,589,204.18-7,170,934.67
三、筹资活动产生的现金流量:
  取得借款收到的现金-25,664,755.5825,664,755.5820,664,755.58
  筹资活动现金流入平衡项目-000
  筹资活动现金流入小计-25,664,755.5825,664,755.5820,664,755.58
  偿还债务支付的现金-25,664,755.5817,653,171.3410,000,000
  分配股利、利润或偿付利息支付的现金12,287,869.1854,044,722.9845,726,520.92173,000
  支付其他与筹资活动有关的现金7,520,375.3525,823,977.618,303,602.2513,751,858.9
  筹资活动现金流出小计19,808,244.53105,533,456.1681,683,294.5123,924,858.9
  筹资活动产生的现金流量净额-19,808,244.53-79,868,700.58-56,018,538.93-3,260,103.32
四、汇率变动对现金及现金等价物的影响-1,553,587.611,815,915.652,251,028.462,110,728
五、现金及现金等价物净增加额3,893,235.5614,069,717.72-4,842,402.2431,105,818.75
  加:期初现金及现金等价物余额52,818,664.8938,748,947.1738,748,947.1738,748,947.17
  期末现金及现金等价物余额56,711,900.4552,818,664.8933,906,544.9369,854,765.92
补充资料:
  净利润-34,294,767.32-24,761,426.27
  资产减值准备-16,017,088.85-5,159,549.6
  固定资产和投资性房地产折旧-28,073,318.34-13,817,549.06
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧-28,073,318.34-13,817,549.06
  无形资产摊销-502,802.06-246,229.07
  长期待摊费用摊销-42,971,430.92-21,408,810.13
  处置固定资产、无形资产和其他长期资产的损失--41,517.55--
  固定资产报废损失-301,281.49-76,317.06
  公允价值变动损失--6,996,140.63--3,313,005.94
  财务费用-6,359,371.37-2,061,838.73
  投资损失--105,380.53--105,380.53
  递延所得税--15,539,703.94--8,508,051.84
  其中:递延所得税资产减少--16,388,888.96--8,819,118.59
    递延所得税负债增加-849,185.02-311,066.75
  存货的减少--16,890,222.3-3,102,121.71
  经营性应收项目的减少--16,791,347.52--58,386,299.29
  经营性应付项目的增加-34,331,004.08-24,833,860.84
  其他-6,116,980.22-2,817,058.87
  现金的期末余额-52,818,664.89-69,854,765.92
  减:现金的期初余额-38,748,947.17-38,748,947.17
  现金及现金等价物的净增加额-14,069,717.72-31,105,818.75
公告日期2026-04-292026-04-292025-10-302025-08-28
审计意见(境内)标准无保留意见
TOP↑